Ranieri G - Search Results

1

Angiogenesis and angiogenesis inhibitors: a new potential anticancer therapeutic strategy.

Ranieri G, Gasparini G. Ranieri G, et al. Curr Drug Targets Immune Endocr Metabol Disord. 2001 Nov;1(3):241-53. doi: 10.2174/1568008013341073. Curr Drug Targets Immune Endocr Metabol Disord. 2001. PMID: 12477290 Review.

2

Bone marrow angiogenesis and progression in multiple myeloma.

Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F, Dammacco F. Vacca A, et al. Among authors: ranieri g. Br J Haematol. 1994 Jul;87(3):503-8. doi: 10.1111/j.1365-2141.1994.tb08304.x. Br J Haematol. 1994. PMID: 7527645

3

Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients.

Gasparini G, Toi M, Verderio P, Ranieri G, Dante S, Bonoldi E, Boracchi P, Fanelli M, Tominaga T. Gasparini G, et al. Among authors: ranieri g. Int J Oncol. 1998 May;12(5):1117-25. doi: 10.3892/ijo.12.5.1117. Int J Oncol. 1998. PMID: 9538138

4

Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer.

Gasparini G, Brooks PC, Biganzoli E, Vermeulen PB, Bonoldi E, Dirix LY, Ranieri G, Miceli R, Cheresh DA. Gasparini G, et al. Among authors: ranieri g. Clin Cancer Res. 1998 Nov;4(11):2625-34. Clin Cancer Res. 1998. PMID: 9829725

5

A unique case of eccrine porocarcinoma with pulmonary lymphangitis and pericardial involvement: biological characterization and clinical aggressiveness.

Biondi E, Ranieri G, Nicolò A, Gasparini G. Biondi E, et al. Among authors: ranieri g. Oncology. 2000 Sep;59(3):190-5. doi: 10.1159/000012160. Oncology. 2000. PMID: 11053985

6

Development of vasculature targeting strategies for the treatment of chronic inflammatory diseases.

Ranieri G, Ria R, Roccaro AM, Vacca A, Ribatti D. Ranieri G, et al. Curr Drug Targets Inflamm Allergy. 2005 Feb;4(1):13-22. doi: 10.2174/1568010053622966. Curr Drug Targets Inflamm Allergy. 2005. PMID: 15720230 Review.

7

Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic.

Ranieri G, Patruno R, Ruggieri E, Montemurro S, Valerio P, Ribatti D. Ranieri G, et al. Curr Med Chem. 2006;13(16):1845-57. doi: 10.2174/092986706777585059. Curr Med Chem. 2006. PMID: 16842197 Review.

8

Drug targets to pro-angiogenetic factors with special reference to primary peritoneal mesothelioma.

Ranieri G, Ruggieri E, Falco G, Zizzo N, Mattioli E, Zito AF, Patruno R, Gasparini G. Ranieri G, et al. Endocr Metab Immune Disord Drug Targets. 2006 Sep;6(3):271-7. doi: 10.2174/187153006778250028. Endocr Metab Immune Disord Drug Targets. 2006. PMID: 17017978 Review.

9

A possible role of thymidine phosphorylase expression and 5-fluorouracil increased sensitivity in oropharyngeal cancer patients.

Ranieri G, Grammatica L, Patruno R, Zito AF, Valerio P, Iacobellis S, Gadaleta C, Gasparini G, Ribatti D. Ranieri G, et al. J Cell Mol Med. 2007 Mar-Apr;11(2):362-8. doi: 10.1111/j.1582-4934.2007.00007.x. Epub 2007 Mar 22. J Cell Mol Med. 2007. PMID: 17378915 Free PMC article.

10

Tryptase-positive mast cells correlate with angiogenesis in early breast cancer patients.

Ranieri G, Ammendola M, Patruno R, Celano G, Zito FA, Montemurro S, Rella A, Di Lecce V, Gadaleta CD, Battista De Sarro G, Ribatti D. Ranieri G, et al. Int J Oncol. 2009 Jul;35(1):115-20. doi: 10.3892/ijo_00000319. Int J Oncol. 2009. PMID: 19513558

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters